Continuing Medical Education Information

 

AACE Endocrine University

EU Y2 Event start date: 11/17/2022
Credit claim deadline: 12/31/2022

 

Statement of Need

Endocrine University® is designed to provide a forum for endocrinology Fellows-in-Training to enhance their endocrine curriculum, particularly in disease management and practice management skills, which has become essential to the practice of endocrinology.

 

Target Audience

This program is intended for final year endocrine Fellows-in-Training.

 

Learning Objectives

By the end of the meeting, participants will be able to:

  • Effectively utilize new diagnostic technology that has become essential to the practice of endocrinology.
  • Apply the most up-to-date guidelines and evidence-based practices for the diagnosis and treatment of endocrine-related disorders.
  • Integrate the latest evidence-based research for diagnosis and treatment of emerging areas of endocrine-related practice.

 

Accreditation and Designation Statements

ACCME

The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this other (live virtual) activity for a maximum of 18.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosure and Conflicts of Interest Policy

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

 

Planners

Planner Name Ineligible Company Relevant Financial Relationship 
Sara E. Lubitz, MD, FACE Hologic 
Zealand Pharma
Eli Lilly 
Takeda 
Amryt 
Stock Ownership 
Stock Ownership 
Stock Ownership 
Site PI Research Funding
Site PI Research Funding
Matthew J. Levine, MD, FACE Eli Lilly 
Mannkind
Novo Nordisk 
Speakers Bureau, Honoraria 
Consultant
Speakers Bureau, Honoraria 

 

All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

 

Faculty Disclosures

Faculty Name Ineligible Company Relevant Financial Relationship 
Ejigayehu Abate, MD Ascendis Speakers Bureau, Consultant 
Brandi Addison, MD AstraZeneca 
Corcept 
Eli Lilly
Janssen 
Novo Nordisk 
Sanofi
Speakers Bureau
Speakers Bureau
Speakers Bureau 
Research Funding. Project completed 12/2021 
Speakers Bureau, Consultant 
Speakers Bureau 
Robert Adler, MD Radius Health Research Funding to Institution 
Caroline Apovian, MD Abbott Nutrition 
Allergan, Inc 
Altimmune, Inc
Cowen and Company, LLC
Curavit Clinical Research
EnteroMedics 
Gelesis 
Jazz Pharmaceuticals, Inc
L-Nutra, Inc 
NeuroBo Pharmaceuticals 
NIH 
Novo Nordisk 
Pain Script Corporation
PCORI 
Real Appeal
Rhythm Pharmaceuticals
Riverview School 
Roman Health Ventures, Inc 
Scientific Intake Ltd. Co.
Tivity Health, Inc. 
Xeno Biosciences
Zafgan Inc. 
Advisory Board 
Advisory Board 
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Research Funding 
Research Funding, Advisory Board
Advisory Board
Research Funding 
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Advisory Board
Richard J. Auchus, MD, PhD, FACE Adrenas Therapeutics 
Corcept
Crinetics
Diurnal, LTD
H Lundbeck A/S 
Janssen Pharmaceuticals 
Neurocrine Biosciences
Novartis Pharmaceuticals
OMass Therapeutics
PhaseBio Pharmaceuticals
Quest Diagnostics
Recordati Rare Diseases
Spruce Biosciences
Strongbridge Biopharma/Xeris
Consultant 
Research Funding, Consultant 
Consultant 
Research Funding 
Consultant 
Consultant 
Research Funding
Research Funding, Consultant 
Consultant 
Consultant 
Consultant
Consultant
Research Funding
Consultant
Irina Bancos, MD Adrenas
Corcept
HRA Pharma 
Lantheus 
Recordati 
Sparrow 
Spruce
Consultant 
Consultant 
Consultant 
Consultant 
Consultant 
Consultant 
Consultant 
Shalender Bhasin, MD AbbVie 
Aditum 
FPT 
McGraw Hill 
MIB
NIA
NICHD 
NINR 
OPKO
PCORI 
Transition Therapeutics
Xyone  
PI on research grant 
Consultant 
Stock Ownership 
Royalties
PI on research grant
Research Funding
Research Funding
Research Funding
Honorarium
Research Funding
PI on research grant 
Stock Ownership 
Dan Bessesen, MD Eli Lilly 
Novo Nordisk
Honorarium
Honorarium, Site PI  
Dana Erickson, MD Clarivate Analytics Consultant Fee 
Amir Hamrahian, MD Corcept 
HRA Pharma 
Xeris Pharmaceutical
Research, Advisory Board, Consultant 
Advisory Board, Consultant
Advisory Board, Consultant
Betul Hatipoglu, MD Noom App Research Funding 
Silvio Inzucchi, MD Abbott 
AstraZeneca
Boehringer Ingelheim
Esperion 
Lexicon 
Merck/Pfizer
Novo Nordisk
VTV Therapeutics
Consultant 
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Laurence Katznelson, MD Ascendis 
Camarus 
Crinetics
Novo Nordisk 
Recordati 
Strongbridge 
Research Funding 
Research Funding, Consultant 
Research Funding 
Consultant
Consultant
Consultant
Ann Kearns, MD Amgen Research Funding 
Vijay Nambi, MD Amgen Site PI for industry sponsored study 
Steven Petak, MD, JD, MACE Alexion
Amgen  
Speakers Bureau 
Speakers Bureau
Susan Samson, MD, PhD, FRCPC, FACE Chiasma/Amryt 
Corcept 
Clinical Trial Steering Chair 
Site PI 
Meera Shah, MB, ChB, MRCP Pendulum Therapeutics Research Funding 
Vinaya Simha, MD, MBBS Pfizer Consultant 
Arthi Thirumalai, MD Fractyl Laboratories 
Novo Nordisk
Site PI for industry sponsored study 
PI on research grant 
Anand Vaidya, MD, MMSc Corcept  
HRA Pharma 
Mineralys 
Consultant 
Consultant 
Clinical Advisory Board 
Robert Wermers, MD Alexion 
Inozyme
Research Funding 
Research Funding
Kathleen Wyne, MD Aegerion Pharmaceuticals 
Intercept Pharmaceuticals 
Research Funding 
Research Funding 
William Young, MD Bayer AG 
Crinetics 
Stock Ownership, Drug Safety Monitoring Board 
Stock Ownership, Scientific Advisory Board, Consultant 
Kevin Yuen, MD, FRCP, FACE Amryt 
Ascendis 
Corcept
Crinetics
Ipsen 
Novo Nordisk 
Recordati 
Sandoz 
Strongbridge
Research Funding, Consultant 
Research Funding, Consultant 
Research Funding, Speakers Bureau, Consultant 
Consultant
Consultant
Speakers Bureau, Consultant 
Speakers Bureau, Consultant 
Consultant
Consultant

 

All of the relevant financial relationships listed for these individuals have been mitigated. All other faculty for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

Reviewers

None of the reviewers for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

 

Commercial Support

This activity is supported by educational grants from the following:

  • Abbott Diabetes Care
  • Amgen
  • Corcept Therapeutics
  • Lilly USA, LLC
  • Medtronic
  • Novo Nordisk Inc.
  • Pfizer Inc.
  • Pfizer-Merck Alliance
  • Radius Health, Inc.
  • Recordati Rare Diseases
  • Rhythm Pharmaceuticals
  • Ultragenyx Pharmaceutical Inc.